Documentos de Macías A.E. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Publisher: "Bionatura"

Subtipo de publicación

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(3)

Medicina y salud(2)

Área de conocimiento

Farmacología(2)

Inmunología(1)

Año de Publicación

Origen

Palabras Claves

And High-grade glioma(1)

Anti-idiotypic(1)

Evaluation of Nimotuzumab for the treatment of head and neck cancer: Meta-analysis of controlled trials

Abstract: Nimotuzumab, humanized monoclonal antibody, directed against the epidermal growth factor receptor: h

Palabras claves:

Epidermal growth factor receptor, Head and neck tumors, Humanized monoclonal antibody, nimotuzumab

Aliuska Frías, Carmen Elena Viada, García L., Mabel Álvarez, Macías A.E., Mestre B.F., Osorio M., Pérez Ruiz L., Ramos M., Robaina M., Santiesteban Y., Tania Crombet, Vega A.M.

Evaluation of racotumomab for the treatment of lung cancer: Meta-analysis of controlled trials of the CIM

Abstract: Racotumomab is a therapeutic cancer vaccine entirely developed in Cuba and licensed in the country f

Palabras claves:

immunotherapy, Non-small cell lung cancer, Oncological vaccines, Racotumomab, Vaccinal treatment

Alfonso S., Aliuska Frías, Ballesteros J., Carmen Elena Viada, Hernández M., Mabel Álvarez, Macías A.E., Martha M. Fors-López, Quintero J., Robaina M.

Nimotuzumab for the treatment of patients with malignant glioma. Comparison between pre-registration and post-approved studies

Abstract: Nimotuzumab is a monoclonal antibody targeted against the epidermal growth factor receptor approved

Palabras claves:

And High-grade glioma, Controlled clinical studies, nimotuzumab, Postmarking studies, Target therapies

Aliuska Frías, Carmen Elena Viada, García L., Luaces P.L.o., Mabel Álvarez, Macías A.E., Santiesteban Y., Saurez G., Tania Crombet

Security 1E10 anti-idiotypic vaccine in patients with tumors of different locations

Abstract: Cancer is a leading cause of death in Cuba and the world. Lung cancer is the leading cause of death,

Palabras claves:

Anti-idiotypic, Breast, Cáncer, COLON, Non-small cell lung vaccine, security, Small cell lung

Alfonso S., Carmen Elena Viada, García E., Guerra P.P., Hernández M., Macías A.E., MARTHA FORS, Martha M. Fors-López, Mendoza I.C., Neninger Vinageras E., Pérez Ruiz L., Santiesteban E.R., Vázquez A.M.